Nearmap should be bought by all those ethical superfunds/managed funds. Never hurts to broaden the types of investors.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025